Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange may become a broker

8/16/24 MOEX

Sovcomflot reports for 6 months of 2024 by IFRS

8/16/24 FLOT

Trades in shares of ICAO Headhunter will begin on September 25

8/15/24 HEAD

Cherkizovo reports for 6 6 months of 2024 by IFRS

8/15/24 GCHE

Rosgosstrakh doubles half-year net profit

8/15/24 RGSS

Seligdar plans to start geological exploration of Dzhekondinskaya area in 2025

8/15/24 SELG

Renaissance Insurance will receive VSK - Life Line portfolio

8/15/24 RENI

SFI redeemed 55% of its shares

8/15/24 SFIN

Sovcombank postpones additional share issue for the acquisition of Home Bank to 2025

8/15/24 SVCB

X5 Retail Group reported for 6 months of 2024 by IFRS

8/15/24 X5